Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2006 - CURE FOR CANCER WORTH 50 TRILLION DOLLARS.

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Jan 12, 2022 10:28pm

333 Views

Post# 34311155

RE:RE:RE:RE:RE:2006 - CURE FOR CANCER WORTH 50 TRILLION DOLLARS.

We may pretty soon make Merck's Keytruda Blockbuster cancer drug look like a Placebo in comparison to TLD-1433 for NMIBC. IMO of course Let's hope data continues to be as stellar as in last update on Optimized treated patients

floatinketucky wrote: 2b7f6fab,
Yes you always have great posts thanks for your input. I suppose my Napkin scratch would consider
Merck has a market cap of $205 billion and half rev from keytruda?? ok Ima throw my dart

I taking 100 billion figure and throw out 75% to respect consevartive approach.
25 billion / 300,000 million shares $83.per share on the back of crumpled napkin???????

2b7f6fab wrote: Merck has a market cap of $205 billion. At least half that market cap is due to its block buster cancer drug keytruda. TLTFF with 290 million shares fully diluted would need to trade at $345/sh to reach $100 billion market cap.

gojotv! wrote:
Is it any wonder that for months and years now, corporate agents have been on this boards saying, "I'm happy to sell at $2.00 share, not you?... What about $2.10...?"
They must think we TLT longs can't do math.
Anything under $300/share... AMERICAN... Puh- leeease...
If Apple is worth that with their enormous share float...
Better yet, let's see this to becoming a Canadian Pharm-Tech company and get lifetime dividends for ourselves and generations of our families to come.
That's the "QUAHN", baby!
GLTA!

winr88 wrote:

Value of $1 from 2006 to 2022

$1 in 2006 is equivalent in purchasing power to about $1.38 today, an increase of $0.38 over 16 years. The dollar had an average inflation rate of 2.03% per year between 2006 and today, producing a cumulative price increase of 37.87%.

This means that today's prices are 1.38 times higher than average prices since 2006, according to the Bureau of Labor Statistics consumer price index. A dollar today only buys 72.46% of what it could buy back then.

The inflation rate in 2006 was 3.23%. The current year-over-year inflation rate (2021 to 2022) is now 6.81%. If this number holds, $1 today will be equivalent in buying power to $1.07 next year. The current inflation rate page gives more detail on the latest inflation rates.

Based on 50 trillion at plus 38% is 69 Trillion today.